John Dobak - Sep 8, 2021 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role
Chief Executive Officer, Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Stock symbol
DMTK
Transactions as of
Sep 8, 2021
Transactions value $
-$42,053
Form type
4
Date filed
9/10/2021, 08:12 PM
Previous filing
Jul 2, 2021
Next filing
Sep 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale -$42.1K -1.16K -0.25% $36.19* 456K Sep 8, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.
F2 Includes 359 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2021.